Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $8.9600 (-12.67%) ($8.9600 - $8.9600) on Thu. Feb. 25, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.28% (three month average) | RSI | 26 | Latest Price | $8.9600(-12.67%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -6.5% a day on average for past five trading days. | Weekly Trend | CGEN declines -9.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) ARKG(72%) XBI(72%) ARKK(69%) IWO(66%) IBB(64%) | Factors Impacting CGEN price | CGEN will decline at least -2.14% in a week (0% probabilities). VIXM(-45%) VXX(-40%) UUP(-21%) IGOV(-6%) TBT(-3%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.14% (StdDev 4.28%) | Hourly BBV | -2.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-6.33(-170.65%) | Inflection Point | Yes | Resistance Level | $12.4 | 5 Day Moving Average | $10.85(-17.42%) | 10 Day Moving Average | $11.84(-24.32%) | 20 Day Moving Average | $12.4(-27.74%) | To recent high | -36.9% | To recent low | 0% | Market Cap | $741m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |